HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-n-butyl haloperidol iodide protects cardiac microvascular endothelial cells from hypoxia/reoxygenation injury by down-regulating Egr-1 expression.

AbstractAIMS:
Our previous studies have shown that N-n-butyl haloperidol iodide (F2) can antagonize myocardial ischemia/reperfusion (I/R) injury by down-regulating the early growth response (Egr)-1 expression, but the molecular mechanisms are not well understood. Because there is evidence implicating myocardial I/R injury is closely associated with endothelial dysfunction. The present study is to test the hypothesis that the protective effects of F2 on myocardial I/R injury is related closely with down-regulating Egr-1 expression on cardiac microvascular endothelial cells (CMECs).
METHODS:
A model of cultured CMECs exposed to hypoxia/reoxygenation (H/R) was developed. With antisense Egr-1 oligodeoxyribonucleotide (ODN), the relationship between Egr-1 expression and endothelial H/R injury was investigated. Egr-1 mRNA and protein expression were examined by real-time fluorescent quantitative PCR, immunocytochemical staining and Western-blot analysis. Lactate dehydrogenase (LDH), malondialdehyde (MDA), superoxide dismutase (SOD), intercellular adhesion molecule-1 (ICAM-1), adherence of neutrophil and platelets, and cell viability were measured after H/R to evaluate the degree of endothelial injury.
RESULTS:
Pretreatment with antisense Egr-1 ODN significantly reduced Egr-1 protein expression and attenuated injury of CMECs. Consistent with down-regulation of Egr-1 expression by F2, inflammation and other damage were significantly reduced as evidenced by a decrease of ICAM-1 expression, reduction of neutrophil and platelets adherence, increase in SOD, and decreases in MDA and LDH levels, resulting in the rise of cell viability.
CONCLUSIONS:
We demonstrate a protective effect of F2 in CMECs against H/R injury by down-regulating Egr-1 expression, which might be play a vital role in the pathogenesis of myocardial I/R injury.
AuthorsYanqiong Zhou, Yanmei Zhang, Fenfei Gao, Fuxiao Guo, Jinzhi Wang, Wenfeng Cai, Yicun Chen, Jinhong Zheng, Ganggang Shi
JournalCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (Cell Physiol Biochem) Vol. 26 Issue 6 Pg. 839-48 ( 2010) ISSN: 1421-9778 [Electronic] Germany
PMID21220915 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 S. Karger AG, Basel.
Chemical References
  • Early Growth Response Protein 1
  • N-n-butyl haloperidol iodide
  • Oligodeoxyribonucleotides, Antisense
  • Intercellular Adhesion Molecule-1
  • Malondialdehyde
  • L-Lactate Dehydrogenase
  • Superoxide Dismutase
  • Haloperidol
Topics
  • Animals
  • Blood Platelets (physiology)
  • Cell Adhesion
  • Cell Hypoxia
  • Cell Survival
  • Cells, Cultured
  • Down-Regulation
  • Early Growth Response Protein 1 (genetics, metabolism, physiology)
  • Endothelial Cells (cytology, metabolism)
  • Endothelium, Vascular (cytology)
  • Female
  • Haloperidol (analogs & derivatives, pharmacology)
  • Intercellular Adhesion Molecule-1 (metabolism)
  • L-Lactate Dehydrogenase (metabolism)
  • Male
  • Malondialdehyde (metabolism)
  • Myocardial Reperfusion Injury (genetics, metabolism)
  • Myocardium (cytology)
  • Neutrophils (immunology, physiology)
  • Oligodeoxyribonucleotides, Antisense (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Superoxide Dismutase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: